[Drug eruptions caused by noncorticoid anti-inflammatory agents].
Non-steroidal anti-inflammatory drugs (NSAI) may elicit various kinds of cutaneous side effects. The commonest ones are non-specific erythematous eruptions, sometimes with a phototoxic distribution, and urticaria. Vasculitis and severe bullous eruptions (Stevens-Johnson's syndrome and Toxic Epidermal Necrolysis) are rare but may have severe outcomes. The overall incidence of cutaneous reactions is about the same for all NSAI, 1 to 3 p. 100, during the clinical studies performed before marketing the drug, but this increases afterwards (up to 45 p. 100 for Benoxaprofen). Drugs with long half-lives may carry a higher risk for severe cutaneous reactions. NSAI are now the main cause of drug induced TEN. Urticarial reactions seem related to pharmacological phenomena while the pathogenic events leading to other kinds of skin reactions remain unknown. An hypersensitivity reaction is postulated. The therapeutic value of corticosteroids for the severe cutaneous side effects of drugs is still controversial.
D000799:Angioedema / Q000139:chemically induced; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000628:therapy; D004890:Erythema / Q000139:chemically induced; D006801:Humans; D011695:IgA Vasculitis / Q000139:chemically induced; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced; D014581:Urticaria / Q000139:chemically induced
D000893:Anti-Inflammatory Agents
Toxidermies dues aux anti-inflammatoires non cortisonés.